[Cancer of the prostate: curative radiotherapy preceded by lymphadenectomy in 20 patients. Follow-up over 10 years].
Twenty patients with prostatic cancer were treated by external beam radiotherapy after ilioobturator lymphadenectomy. The patients could be divided into two groups: Group I: no lymph node invasion and Group II: presence of lymph node metastases. In Group I, only one death was due to cancer and the 6-year survival was 90%. In Group II, 7 deaths were due to cancer and the 6-year survival was 20%. Secondary endocrine treated administered at the time of recurrence appeared to significantly prolong survival in comparison with the stage D1 cancers treated immediately by endocrine therapy.
Sarramon
J P
JP
Service de Chirurgie Urologique, CHU Purpan, Toulouse.
Rischmann
P
P
Albin
N
N
Douchez
J
J
D000368:Aged; D003131:Combined Modality Therapy; D005500:Follow-Up Studies; D006801:Humans; D008197:Lymph Node Excision; D008198:Lymph Nodes / Q000473:pathology; D008207:Lymphatic Metastasis; D008220:Lymphography; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011471:Prostatic Neoplasms / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery*; D011879:Radiotherapy Dosage; D012189:Retrospective Studies; D015996:Survival Rate
Cancer de la prostate: radiothérapie à visée curatrice précédée d'une lymphadénectomie chez vingt patients. Recul supérieur à dix ans.